.On the heels of an FDA being rejected for its chief rivalrous Novo Nordisk, Eli Lilly is pushing on...
.Just a few months after dosing the very first person in a phase 2 test for recently detected gliobl...
.Eli Lilly's hunt for weight problems targets has actually led it to the black genome. The Big Pharm...
.Collection Biosciences is actually carrying on up. The tissue therapy business has added $325 milli...
.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually su...
.Aelis Farma's chances of protecting a fast, beneficial selection on a $100 thousand option settleme...
.ProKidney has actually quit one of a pair of phase 3 tests for its tissue treatment for kidney cond...
.Vaxcyte revealed what professionals named "remarkable" phase 1/2 data for its 31-valent pneumococca...
.Recursion has discovered with a very early examination of its own tech-enabled technique to drug ex...
.Phone it a case of good chemical make up: Acepodia, a biotech based upon Nobel Prize-winning scienc...